Table 1.
Published studies of laparoscopic liver resection for malignancy
| Ref. | Year | n | HCC | CRM | GB CA | Cholangio | Lypmhoma | NET mets | Other | Size (cm) | EBL (mL) | Conversion | OT (min) | M | Death | LOS (d) | Margin (cm) |
| Choi et al[23] | 2013 | 57 | 57 | 0 | 0 | 0 | 0 | 0 | 0.8-5.5 | 150-800 | NA | 95-380 | NA | 0 | 5 17 | 2.08 ± 1.68 | |
| Guerron et al[63] | 2013 | 40 | 40 | 3.3 | 376 ± 122 | 5% | 239 ± 17 | 15% | NA | 3.7 | 1 ± 0.2 | ||||||
| Gumbs et al[21] | 2012 | 40 | 4 | 30 | 6 | 1 | 4 | 5 | NA | 300 | 6% | 265 | 11.30% | NA | 6 (1-31) | NA | |
| Abu Hilal et al[13] | 2012 | 133 | 18 | 83 | 2 | 2 | 17 | 11 | 0.5-14 | (10-4000) | NA | 30-540 | 0 40 % | NA | 0 15 | Pos 0-35% | |
| Topal et al[24] | 2012 | 81 | NA | 50 (10-300) | NA | 120 (80-200) | 11% | 0 | 5 (3-7) | NA | |||||||
| Yoon et al[25] | 2012 | 89 | 89 | 3 ± 1.6 | NA | 4.70% | 2675 ± 138 | NA | NA | NA | 1.4 ± 1.4 | ||||||
| Cannon et al[26] | 2012 | 35 | 35 | NA | 202 | NA | NA | 23% | 0 | 4.8 vs 8.3 | Neg 97% | ||||||
| Ikeda et al[27] | 2012 | 30 | 16 | 13 | 1 | 2.6 ± 1 | 146 (0-550) | 0 | 79-697 | NA | 0 | 5-44 | 5 (1-30) | ||||
| Dagher et al[28] | 2010 | 163 | 163 | 3.6 (1-20) | 250 (30-2000) | 9.20% | 180 (60-655) | 11.60% | 1.20% | 7 (2-76) | 12 (0-58) | ||||||
| Shafaee et al[29] | 2011 | 66 | 3 | 55 | 1 | 3 | 2 | 0.5-12.5 | 300 (0-5000) | 11% | 180 (80-570) | 26% | 0 | 6 (2-42) | 0.3 (0-4) | ||
| Lai et al[30] | 2011 | 56 | 42 | 14 | 0.9-5.4 | 175 (5-2000) | 3.60% | 150 (75-307) | 14.30% | 0 | 6.5 (2-13) | 89.3% R0 | |||||
| Belli et al[31] | 2011 | 65 | 65 | 3.8 (1-9) | 311 ± 180 | 10.70% | NA | 20% | 1.50% | 8.2 (3-15) | NA | ||||||
| Truant et al[32] | 2011 | 36 | 36 | 2.9 ± 1.2 | 452 ± 442 | 19.40% | NA | 25 | 0 | NA | 0.95 | ||||||
| Nguyen et al[43] | 2011 | 108 | 3.2 | 101 | NA | 256 | NA | NA | NA | 1.12, 1.5 | |||||||
| Lee et al[33] | 2011 | 31 | 31 | 2.5 (1.5-9) | 150 (10-1610) | 18.20% | 225 (100-420) | 6.10% | 0 | 5 (2-15) | 1.8 (0-4) | ||||||
| Hu et al[34] | 2011 | 30 | 30 | 6.7 ± 3.1 | 520 ± 30 | NA | 180 ± 45 | 13.30% | NA | 13 ± 2.1 | NA | ||||||
| Kazaryan et al[35] | 2010 | 107 | 107 | 3 (0.5-12) | 300 (50-4000) | 4.20% | 188 (64-488) | NA | 0.90% | 3 (1-42) | NA | ||||||
| Martin et al[5] | 2010 | 65 | 14% | 48% | 12% | 26% | 4 (2-15) | 150 (20-1000) | 4% | 140 (50-240) | 23% | 1% | 3 (1-13) | Pos 3% | |||
| Zhang et al[41] | 2010 | 70 | 29 | 28 | 2 | 1 | 10 | NA | 8.80% | 150 (20-390) | 14.80% | 0 | 6 (1-20) | Neg 100% | |||
| Tranchart et al[36] | 2010 | 42 | 42 | 3.58 ± 1.75 | 346 ± 435.7 | NA | 233.1 ± 92.7 | 20.40% | 2.40% | 6.7 ± 5.9 | 1.04 ± 0.8 | ||||||
| Yoon et al[8] | 2010 | 69 | 69 | 3.1 ± 1.5 | 7.20% | 280.9 ± 128.2 | 21.70% | NA | 9.9 ± 5.6 | 1.5 ± 1.6 | |||||||
| Nguyen et al[62] | 2009 | 109 | 109 | NA | 200 (20-2500) | 3.70% | 234 (60-555) | 12.00% | NA | 4 (1-22) | Neg 94.4% | ||||||
| Sasaki et al[37] | 2009 | 72 | 37 | 35 | 2.5 (1.5-8.5) | 64 (1-917) | NA | 177 (70-430) | 5.50% | NA | 8.5-10 | 0.6 (0-4) | |||||
| Bryant et al[16] | 2009 | 100 | 64 | 22 | 3 | 11 | NA | (0-2000) | 9.60% | 30-480 | 15.10% | 0 | 7.9 (2-76) | 1.53 (0-5.8) | |||
| Inagaki et al[38] | 2009 | 52 | 36 | 10 | 3 | 3 | 3.1 ± 1.8 | 393 ± 564 | 2.90% | 214 ± 93 | 10% | NA | 17 | NA | |||
| Cho et al[4] | 2009 | 35 | 27 | 8 | 3.4 (1.5-7.5) | 619.5 (20-1800) | NA | 299.9 (80-630) | 27.50% | NA | 10.9 (5-38) | 1.3 (0.2-5) | |||||
| Huang et al[39] | 2009 | 33 | 27 | 3 | 1 | 2 | 3.4 (1-11) | 200 (100-400) | 6.70% | 120 (90-177.5) | 11.11% | NA | 5 | 0.2-3.2 | |||
| Otsuka et al[40] | 2009 | 76 | 55 | 16 | 2 | 3 | 3.68 ± 2.8 | 262 ± 344.8 | NA | 268 ± 123.1 | 11% | 0 | 11.8 ± 7.3 | NA | |||
| Castaing et al[14] | 2009 | 60 | 60 | 3.3 ± 1.1 | NA | 10% | NA | 27% | 1.70% | 10 (5-50) | Neg 87% | ||||||
| Dagher et al[3] | 2009 | 210 | NA | 300 ± 391 | 12% | 250 ± 103.8 | 22% | 1.00% | 6 ± 3.5 | 10.5 ± 13.6 | |||||||
| Zhang et al[41] | 2009 | 49 | 33 | 10 | 6 | 3 | 6.2 (0.8-15) | 280 (10-1000) | NA | NA | NA | 0 | NA | 1.2 (0.5-6) | |||
| Cho et al[42] | 2008 | 71 | 52 | 19 | 3.7 ± 3 | 425 (20-900) | 5% | 240 (30-540) | 15% | 0 | 9 (4-21) | 1 (0.3-6.8) | |||||
| Topal et al[6] | 2008 | 77 | 3.8 (0.5-17) | 500 (10-7000) | 9% | 95 (30-385) | 5.50% | NA | 6 (0-41) | Pos in 1.2% | |||||||
| Chen et al[53] | 2008 | 116 | 116 | 1.3-5.1 | 101.6-667.2 | NA | 118.4-488.7 | 6% | NA | 6 | NA | ||||||
| Buell et al[17] | 2008 | 106 | 36 | 31 | 8 | 31 | 3.1-6.4 | NA | NA | NA | 3.70% | NA | 2.80% | ||||
| Hompes et al[22] | 2007 | 45 | 8 | 32 | 1 | 4 | 1 | 1 | 4 (0.8-17) | 200 (5-4000) | 6.60% | 115 (45-360) | 24% | 0 | 7 (3-41) | 1 (0.1-3) | |
| Dagher et al[47] | 2007 | 38 | 24 | 9 | 3 | 2 | 3.8 (2.2-8) | 397 (100-2300) | 10% | 227 ± 109 | 16% | 1.40% | 5.9 ± 5.6 | 1.1 (0.1-3.2) | |||
| Koffron et al[48] | 2007 | 103 | NA | 102 | 6% to ha | 99 | 9.30% | 0 | NA | NA | |||||||
| Vibert et al[9] | 2006 | 65 | 16 | 41 | 2 | 3 | 3 | 0.8-18 | NA | 13% | 85-515 | 19% | 1.10% | 11 (3-47) | NA | ||
| Mala et al[10] | 2005 | 47 | 1 | 42 | 1 | 3 | 3 (0.8-15) | 700 (< 100-5000) | 6% | 187 (80-334) | 16% | 0 | 3.5 (1-14) | Pos in 6% | |||
| O'Rourke et al[7] | 2004 | 33 | 22 | 11 | NA | 20-2000 | 9.40% | 40-370 | 14% | 0 | NA | 1.1 (0-3) | |||||
| Inagaki et al[45] | 2003 | 52 | 36 | 3.1 (1-14) | 393 ± 564 (5-3500) | 2.90% | 214 (61-375) | 26.40% | 0 | 14.8 | NA | ||||||
| Gigot et al[59] | 2002 | 37 | 10 | 12 | 5 | 10 | 3.3 (1-6) | NA | 10.80% | NA | 21% | 0 | 7 (2-16) | Pos in 6.7% |
HCC: Hepatocellular carcinoma; CRM: Colorectal metastasis; NET mets: Neuroendocrine metastasis; GB CA: Gallbladder adenocarcinoma; Cholangio: Cholangiocarcinoma; NA: Unavailable; EBL: Estimated blood loss; OT: Operative time; LOS: Length of stay; Margin: Resection margin size; Pos: Positive margin rate; R0: R0 resection rate.